APO Research
Talk to an analyst

APO RESEARCH · REPORT

Similar Biological Medicinal Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Similar Biological Medicinal Products Market Outlook and Growth Opportunities 2026

27 December 2025209 pages

Choose your research edition.

Industry ResearchSimilar Biological Medicinal Products Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Similar Biological Medicinal Products Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Similar Biological Medicinal Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Similar Biological Medicinal Products Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Similar Biological Medicinal Products Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Similar Biological Medicinal Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Similar Biological Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Similar Biological Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Similar Biological Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Similar Biological Medicinal Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Similar Biological Medicinal Products market include CITIC Guojian, Changchun High-tech, Innovent Biologics, Saijin Biotechnology, Fuhong Hanlin, Baitai Biology, Biotech, Sandoz and Samsung Bioepies Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Similar Biological Medicinal Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Similar Biological Medicinal Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Similar Biological Medicinal Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Similar Biological Medicinal Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Similar Biological Medicinal Products Segment by Company

CITIC Guojian

Changchun High-tech

Innovent Biologics

Saijin Biotechnology

Fuhong Hanlin

Baitai Biology

Biotech

Sandoz

Samsung Bioepies Co., Ltd

Amgen

Celltrion Healthcare

Coherus Biosciences, Inc.

Eli Lilly

Novartis AG

Pfizer Inc

Stada Arzneimittel AG

Teva Pharmaceutical Industries Ltd

Viatris

Similar Biological Medicinal Products Segment by Type

Monoclonal Antibodies

Anti-inflammatory Drugs

Immunomodulator

Recombinant Hormone

Others

Similar Biological Medicinal Products Segment by Application

Oncology

Blood Disorders

Growth Hormone Deficiency

Chronic and Autoimmune Diseases

Others

Similar Biological Medicinal Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Similar Biological Medicinal Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Similar Biological Medicinal Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Similar Biological Medicinal Products significant trends, drivers, influence factors in global and regions.

6. To analyze Similar Biological Medicinal Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Similar Biological Medicinal Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Similar Biological Medicinal Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Similar Biological Medicinal Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Similar Biological Medicinal Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Similar Biological Medicinal Products industry.

Chapter 3: Detailed analysis of Similar Biological Medicinal Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Similar Biological Medicinal Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Similar Biological Medicinal Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Similar Biological Medicinal Products Industry Trends Table 2. Similar Biological Medicinal Products Industry Drivers Table 3. Similar Biological Medicinal Products Industry Opportunities and Challenges Table 4. Similar Biological Medicinal Products Industry Restraints Table 5. Global Similar Biological Medicinal Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Similar Biological Medicinal Products Revenue Share by Company (2021-2026) Table 7. Global Similar Biological Medicinal Products Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Similar Biological Medicinal Products Sales Volume Share by Company (2021-2026) Table 9. Global Similar Biological Medicinal Products Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Similar Biological Medicinal Products Company Ranking, (2024-2026) & (USD Million) Table 11. Global Similar Biological Medicinal Products Key Company Manufacturing Base & Headquarters Table 12. Global Similar Biological Medicinal Products Company, Product Type & Application Table 13. Global Similar Biological Medicinal Products Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Similar Biological Medicinal Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Monoclonal Antibodies Table 18. Significant Companies of Anti-inflammatory Drugs Table 19. Significant Companies of Immunomodulator Table 20. Significant Companies of Recombinant Hormone Table 21. Significant Companies of Others Table 22. Global Similar Biological Medicinal Products Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 23. Global Similar Biological Medicinal Products Sales Volume by Type (2021-2026) & (Tons) Table 24. Global Similar Biological Medicinal Products Sales Volume by Type (2027-2032) & (Tons) Table 25. Global Similar Biological Medicinal Products Sales Volume Share by Type (2021-2026) Table 26. Global Similar Biological Medicinal Products Sales Volume Share by Type (2027-2032) Table 27. Global Similar Biological Medicinal Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Similar Biological Medicinal Products Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Similar Biological Medicinal Products Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Similar Biological Medicinal Products Sales Value Share by Type (2021-2026) Table 31. Global Similar Biological Medicinal Products Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Oncology Table 33. Significant Companies of Blood Disorders Table 34. Significant Companies of Growth Hormone Deficiency Table 35. Significant Companies of Chronic and Autoimmune Diseases Table 36. Significant Companies of Others Table 37. Global Similar Biological Medicinal Products Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 38. Global Similar Biological Medicinal Products Sales Volume by Application (2021-2026) & (Tons) Table 39. Global Similar Biological Medicinal Products Sales Volume by Application (2027-2032) & (Tons) Table 40. Global Similar Biological Medicinal Products Sales Volume Share by Application (2021-2026) Table 41. Global Similar Biological Medicinal Products Sales Volume Share by Application (2027-2032) Table 42. Global Similar Biological Medicinal Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Similar Biological Medicinal Products Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Similar Biological Medicinal Products Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Similar Biological Medicinal Products Sales Value Share by Application (2021-2026) Table 46. Global Similar Biological Medicinal Products Sales Value Share by Application (2027-2032) Table 47. Global Similar Biological Medicinal Products Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 48. Global Similar Biological Medicinal Products Sales by Region (2021-2026) & (Tons) Table 49. Global Similar Biological Medicinal Products Sales Market Share by Region (2021-2026) Table 50. Global Similar Biological Medicinal Products Sales by Region (2027-2032) & (Tons) Table 51. Global Similar Biological Medicinal Products Sales Market Share by Region (2027-2032) Table 52. Global Similar Biological Medicinal Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Similar Biological Medicinal Products Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Similar Biological Medicinal Products Sales Value Share by Region (2021-2026) Table 55. Global Similar Biological Medicinal Products Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Similar Biological Medicinal Products Sales Value Share by Region (2027-2032) Table 57. Global Similar Biological Medicinal Products Market Average Price (US$/Ton) by Region (2021-2026) Table 58. Global Similar Biological Medicinal Products Market Average Price (US$/Ton) by Region (2027-2032) Table 59. Global Similar Biological Medicinal Products Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 60. Global Similar Biological Medicinal Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Similar Biological Medicinal Products Sales by Country (2021-2026) & (Tons) Table 62. Global Similar Biological Medicinal Products Sales Market Share by Country (2021-2026) Table 63. Global Similar Biological Medicinal Products Sales by Country (2027-2032) & (Tons) Table 64. Global Similar Biological Medicinal Products Sales Market Share by Country (2027-2032) Table 65. Global Similar Biological Medicinal Products Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Similar Biological Medicinal Products Sales Value Market Share by Country (2021-2026) Table 67. Global Similar Biological Medicinal Products Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Similar Biological Medicinal Products Sales Value Market Share by Country (2027-2032) Table 69. CITIC Guojian Company Information Table 70. CITIC Guojian Business Overview Table 71. CITIC Guojian Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. CITIC Guojian Similar Biological Medicinal Products Product Portfolio Table 73. CITIC Guojian Recent Development Table 74. Changchun High-tech Company Information Table 75. Changchun High-tech Business Overview Table 76. Changchun High-tech Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Changchun High-tech Similar Biological Medicinal Products Product Portfolio Table 78. Changchun High-tech Recent Development Table 79. Innovent Biologics Company Information Table 80. Innovent Biologics Business Overview Table 81. Innovent Biologics Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Innovent Biologics Similar Biological Medicinal Products Product Portfolio Table 83. Innovent Biologics Recent Development Table 84. Saijin Biotechnology Company Information Table 85. Saijin Biotechnology Business Overview Table 86. Saijin Biotechnology Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Saijin Biotechnology Similar Biological Medicinal Products Product Portfolio Table 88. Saijin Biotechnology Recent Development Table 89. Fuhong Hanlin Company Information Table 90. Fuhong Hanlin Business Overview Table 91. Fuhong Hanlin Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Fuhong Hanlin Similar Biological Medicinal Products Product Portfolio Table 93. Fuhong Hanlin Recent Development Table 94. Baitai Biology Company Information Table 95. Baitai Biology Business Overview Table 96. Baitai Biology Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Baitai Biology Similar Biological Medicinal Products Product Portfolio Table 98. Baitai Biology Recent Development Table 99. Biotech Company Information Table 100. Biotech Business Overview Table 101. Biotech Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. Biotech Similar Biological Medicinal Products Product Portfolio Table 103. Biotech Recent Development Table 104. Sandoz Company Information Table 105. Sandoz Business Overview Table 106. Sandoz Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. Sandoz Similar Biological Medicinal Products Product Portfolio Table 108. Sandoz Recent Development Table 109. Samsung Bioepies Co., Ltd Company Information Table 110. Samsung Bioepies Co., Ltd Business Overview Table 111. Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 112. Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Product Portfolio Table 113. Samsung Bioepies Co., Ltd Recent Development Table 114. Amgen Company Information Table 115. Amgen Business Overview Table 116. Amgen Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 117. Amgen Similar Biological Medicinal Products Product Portfolio Table 118. Amgen Recent Development Table 119. Celltrion Healthcare Company Information Table 120. Celltrion Healthcare Business Overview Table 121. Celltrion Healthcare Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 122. Celltrion Healthcare Similar Biological Medicinal Products Product Portfolio Table 123. Celltrion Healthcare Recent Development Table 124. Coherus Biosciences, Inc. Company Information Table 125. Coherus Biosciences, Inc. Business Overview Table 126. Coherus Biosciences, Inc. Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 127. Coherus Biosciences, Inc. Similar Biological Medicinal Products Product Portfolio Table 128. Coherus Biosciences, Inc. Recent Development Table 129. Eli Lilly Company Information Table 130. Eli Lilly Business Overview Table 131. Eli Lilly Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 132. Eli Lilly Similar Biological Medicinal Products Product Portfolio Table 133. Eli Lilly Recent Development Table 134. Novartis AG Company Information Table 135. Novartis AG Business Overview Table 136. Novartis AG Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 137. Novartis AG Similar Biological Medicinal Products Product Portfolio Table 138. Novartis AG Recent Development Table 139. Pfizer Inc Company Information Table 140. Pfizer Inc Business Overview Table 141. Pfizer Inc Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 142. Pfizer Inc Similar Biological Medicinal Products Product Portfolio Table 143. Pfizer Inc Recent Development Table 144. Stada Arzneimittel AG Company Information Table 145. Stada Arzneimittel AG Business Overview Table 146. Stada Arzneimittel AG Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 147. Stada Arzneimittel AG Similar Biological Medicinal Products Product Portfolio Table 148. Stada Arzneimittel AG Recent Development Table 149. Teva Pharmaceutical Industries Ltd Company Information Table 150. Teva Pharmaceutical Industries Ltd Business Overview Table 151. Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 152. Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Product Portfolio Table 153. Teva Pharmaceutical Industries Ltd Recent Development Table 154. Viatris Company Information Table 155. Viatris Business Overview Table 156. Viatris Similar Biological Medicinal Products Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 157. Viatris Similar Biological Medicinal Products Product Portfolio Table 158. Viatris Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Similar Biological Medicinal Products Distributors List Table 162. Similar Biological Medicinal Products Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Similar Biological Medicinal Products Product Image Figure 2. Global Similar Biological Medicinal Products Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Similar Biological Medicinal Products Sales Value (2021-2032) & (US$ Million) Figure 4. Global Similar Biological Medicinal Products Sales (2021-2032) & (Tons) Figure 5. Global Similar Biological Medicinal Products Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Similar Biological Medicinal Products Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Monoclonal Antibodies Image Figure 10. Anti-inflammatory Drugs Image Figure 11. Immunomodulator Image Figure 12. Recombinant Hormone Image Figure 13. Others Image Figure 14. Global Similar Biological Medicinal Products Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Similar Biological Medicinal Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Similar Biological Medicinal Products Sales Volume Share by Type (2021-2032) Figure 17. Global Similar Biological Medicinal Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Similar Biological Medicinal Products Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Similar Biological Medicinal Products Sales Value Share by Type (2021-2032) Figure 20. Oncology Image Figure 21. Blood Disorders Image Figure 22. Growth Hormone Deficiency Image Figure 23. Chronic and Autoimmune Diseases Image Figure 24. Others Image Figure 25. Global Similar Biological Medicinal Products Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 26. Global Similar Biological Medicinal Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Similar Biological Medicinal Products Sales Volume Share by Application (2021-2032) Figure 28. Global Similar Biological Medicinal Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Similar Biological Medicinal Products Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Similar Biological Medicinal Products Sales Value Share by Application (2021-2032) Figure 31. Global Similar Biological Medicinal Products Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 32. Global Similar Biological Medicinal Products Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Similar Biological Medicinal Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Similar Biological Medicinal Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Similar Biological Medicinal Products Sales Value (2021-2032) & (US$ Million) Figure 36. North America Similar Biological Medicinal Products Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Similar Biological Medicinal Products Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Similar Biological Medicinal Products Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Similar Biological Medicinal Products Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Similar Biological Medicinal Products Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Similar Biological Medicinal Products Sales Value (2021-2032) & (US$ Million) Figure 42. South America Similar Biological Medicinal Products Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Similar Biological Medicinal Products Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Similar Biological Medicinal Products Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Similar Biological Medicinal Products Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Similar Biological Medicinal Products Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Anti-inflammatory Drugs
  • Immunomodulator
  • Recombinant Hormone
  • Others
Applications
  • Oncology
  • Blood Disorders
  • Growth Hormone Deficiency
  • Chronic and Autoimmune Diseases
  • Others
Companies covered
  • CITIC Guojian
  • Changchun High-tech
  • Innovent Biologics
  • Saijin Biotechnology
  • Fuhong Hanlin
  • Baitai Biology
  • Biotech
  • Sandoz
  • Samsung Bioepies Co., Ltd
  • Amgen
  • Celltrion Healthcare
  • Coherus Biosciences, Inc.
  • Eli Lilly
  • Novartis AG
  • Pfizer Inc
  • Stada Arzneimittel AG
  • Teva Pharmaceutical Industries Ltd
  • Viatris

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Similar Biological Medicinal Products Sales Value (2021-2032)
  4. 1.2.2 Global Similar Biological Medicinal Products Sales Volume (2021-2032)
  5. 1.2.3 Global Similar Biological Medicinal Products Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Similar Biological Medicinal Products Market Dynamics
  1. 2.1 Similar Biological Medicinal Products Industry Trends
  2. 2.2 Similar Biological Medicinal Products Industry Drivers
  3. 2.3 Similar Biological Medicinal Products Industry Opportunities and Challenges
  4. 2.4 Similar Biological Medicinal Products Industry Restraints
3 Similar Biological Medicinal Products Market by Company
  1. 3.1 Global Similar Biological Medicinal Products Company Revenue Ranking in 2025
  2. 3.2 Global Similar Biological Medicinal Products Revenue by Company (2021-2026)
  3. 3.3 Global Similar Biological Medicinal Products Sales Volume by Company (2021-2026)
  4. 3.4 Global Similar Biological Medicinal Products Average Price by Company (2021-2026)
  5. 3.5 Global Similar Biological Medicinal Products Company Ranking (2024-2026)
  6. 3.6 Global Similar Biological Medicinal Products Company Manufacturing Base and Headquarters
  7. 3.7 Global Similar Biological Medicinal Products Company Product Type and Application
  8. 3.8 Global Similar Biological Medicinal Products Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Similar Biological Medicinal Products Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Similar Biological Medicinal Products Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Similar Biological Medicinal Products Market by Type
  1. 4.1 Similar Biological Medicinal Products Type Introduction
  2. 4.1.1 Monoclonal Antibodies
  3. 4.1.2 Anti-inflammatory Drugs
  4. 4.1.3 Immunomodulator
  5. 4.1.4 Recombinant Hormone
  6. 4.1.5 Others
  7. 4.2 Global Similar Biological Medicinal Products Sales Volume by Type
  8. 4.2.1 Global Similar Biological Medicinal Products Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Similar Biological Medicinal Products Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Similar Biological Medicinal Products Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Similar Biological Medicinal Products Sales Value by Type
  12. 4.3.1 Global Similar Biological Medicinal Products Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Similar Biological Medicinal Products Sales Value by Type (2021-2032)
  14. 4.3.3 Global Similar Biological Medicinal Products Sales Value Share by Type (2021-2032)
5 Similar Biological Medicinal Products Market by Application
  1. 5.1 Similar Biological Medicinal Products Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Blood Disorders
  4. 5.1.3 Growth Hormone Deficiency
  5. 5.1.4 Chronic and Autoimmune Diseases
  6. 5.1.5 Others
  7. 5.2 Global Similar Biological Medicinal Products Sales Volume by Application
  8. 5.2.1 Global Similar Biological Medicinal Products Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Similar Biological Medicinal Products Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Similar Biological Medicinal Products Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Similar Biological Medicinal Products Sales Value by Application
  12. 5.3.1 Global Similar Biological Medicinal Products Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Similar Biological Medicinal Products Sales Value by Application (2021-2032)
  14. 5.3.3 Global Similar Biological Medicinal Products Sales Value Share by Application (2021-2032)
6 Similar Biological Medicinal Products Regional Sales and Value Analysis
  1. 6.1 Global Similar Biological Medicinal Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Similar Biological Medicinal Products Sales by Region (2021-2032)
  3. 6.2.1 Global Similar Biological Medicinal Products Sales by Region: 2021-2026
  4. 6.2.2 Global Similar Biological Medicinal Products Sales by Region (2027-2032)
  5. 6.3 Global Similar Biological Medicinal Products Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Similar Biological Medicinal Products Sales Value by Region (2021-2032)
  7. 6.4.1 Global Similar Biological Medicinal Products Sales Value by Region: 2021-2026
  8. 6.4.2 Global Similar Biological Medicinal Products Sales Value by Region (2027-2032)
  9. 6.5 Global Similar Biological Medicinal Products Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Similar Biological Medicinal Products Sales Value (2021-2032)
  12. 6.6.2 North America Similar Biological Medicinal Products Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Similar Biological Medicinal Products Sales Value (2021-2032)
  15. 6.7.2 Europe Similar Biological Medicinal Products Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Similar Biological Medicinal Products Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Similar Biological Medicinal Products Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Similar Biological Medicinal Products Sales Value (2021-2032)
  21. 6.9.2 South America Similar Biological Medicinal Products Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Similar Biological Medicinal Products Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Similar Biological Medicinal Products Sales Value Share by Country, 2025 VS 2032
7 Similar Biological Medicinal Products Country-level Sales and Value Analysis
  1. 7.1 Global Similar Biological Medicinal Products Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Similar Biological Medicinal Products Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Similar Biological Medicinal Products Sales by Country (2021-2032)
  4. 7.3.1 Global Similar Biological Medicinal Products Sales by Country (2021-2026)
  5. 7.3.2 Global Similar Biological Medicinal Products Sales by Country (2027-2032)
  6. 7.4 Global Similar Biological Medicinal Products Sales Value by Country (2021-2032)
  7. 7.4.1 Global Similar Biological Medicinal Products Sales Value by Country (2021-2026)
  8. 7.4.2 Global Similar Biological Medicinal Products Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Similar Biological Medicinal Products Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Similar Biological Medicinal Products Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Similar Biological Medicinal Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CITIC Guojian
  2. 8.1.1 CITIC Guojian Company Information
  3. 8.1.2 CITIC Guojian Business Overview
  4. 8.1.3 CITIC Guojian Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CITIC Guojian Similar Biological Medicinal Products Product Portfolio
  6. 8.1.5 CITIC Guojian Recent Developments
  7. 8.2 Changchun High-tech
  8. 8.2.1 Changchun High-tech Company Information
  9. 8.2.2 Changchun High-tech Business Overview
  10. 8.2.3 Changchun High-tech Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Changchun High-tech Similar Biological Medicinal Products Product Portfolio
  12. 8.2.5 Changchun High-tech Recent Developments
  13. 8.3 Innovent Biologics
  14. 8.3.1 Innovent Biologics Company Information
  15. 8.3.2 Innovent Biologics Business Overview
  16. 8.3.3 Innovent Biologics Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Innovent Biologics Similar Biological Medicinal Products Product Portfolio
  18. 8.3.5 Innovent Biologics Recent Developments
  19. 8.4 Saijin Biotechnology
  20. 8.4.1 Saijin Biotechnology Company Information
  21. 8.4.2 Saijin Biotechnology Business Overview
  22. 8.4.3 Saijin Biotechnology Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Saijin Biotechnology Similar Biological Medicinal Products Product Portfolio
  24. 8.4.5 Saijin Biotechnology Recent Developments
  25. 8.5 Fuhong Hanlin
  26. 8.5.1 Fuhong Hanlin Company Information
  27. 8.5.2 Fuhong Hanlin Business Overview
  28. 8.5.3 Fuhong Hanlin Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Fuhong Hanlin Similar Biological Medicinal Products Product Portfolio
  30. 8.5.5 Fuhong Hanlin Recent Developments
  31. 8.6 Baitai Biology
  32. 8.6.1 Baitai Biology Company Information
  33. 8.6.2 Baitai Biology Business Overview
  34. 8.6.3 Baitai Biology Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Baitai Biology Similar Biological Medicinal Products Product Portfolio
  36. 8.6.5 Baitai Biology Recent Developments
  37. 8.7 Biotech
  38. 8.7.1 Biotech Company Information
  39. 8.7.2 Biotech Business Overview
  40. 8.7.3 Biotech Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Biotech Similar Biological Medicinal Products Product Portfolio
  42. 8.7.5 Biotech Recent Developments
  43. 8.8 Sandoz
  44. 8.8.1 Sandoz Company Information
  45. 8.8.2 Sandoz Business Overview
  46. 8.8.3 Sandoz Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sandoz Similar Biological Medicinal Products Product Portfolio
  48. 8.8.5 Sandoz Recent Developments
  49. 8.9 Samsung Bioepies Co., Ltd
  50. 8.9.1 Samsung Bioepies Co., Ltd Company Information
  51. 8.9.2 Samsung Bioepies Co., Ltd Business Overview
  52. 8.9.3 Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Product Portfolio
  54. 8.9.5 Samsung Bioepies Co., Ltd Recent Developments
  55. 8.10 Amgen
  56. 8.10.1 Amgen Company Information
  57. 8.10.2 Amgen Business Overview
  58. 8.10.3 Amgen Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Amgen Similar Biological Medicinal Products Product Portfolio
  60. 8.10.5 Amgen Recent Developments
  61. 8.11 Celltrion Healthcare
  62. 8.11.1 Celltrion Healthcare Company Information
  63. 8.11.2 Celltrion Healthcare Business Overview
  64. 8.11.3 Celltrion Healthcare Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Celltrion Healthcare Similar Biological Medicinal Products Product Portfolio
  66. 8.11.5 Celltrion Healthcare Recent Developments
  67. 8.12 Coherus Biosciences, Inc.
  68. 8.12.1 Coherus Biosciences, Inc. Company Information
  69. 8.12.2 Coherus Biosciences, Inc. Business Overview
  70. 8.12.3 Coherus Biosciences, Inc. Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Coherus Biosciences, Inc. Similar Biological Medicinal Products Product Portfolio
  72. 8.12.5 Coherus Biosciences, Inc. Recent Developments
  73. 8.13 Eli Lilly
  74. 8.13.1 Eli Lilly Company Information
  75. 8.13.2 Eli Lilly Business Overview
  76. 8.13.3 Eli Lilly Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Eli Lilly Similar Biological Medicinal Products Product Portfolio
  78. 8.13.5 Eli Lilly Recent Developments
  79. 8.14 Novartis AG
  80. 8.14.1 Novartis AG Company Information
  81. 8.14.2 Novartis AG Business Overview
  82. 8.14.3 Novartis AG Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Novartis AG Similar Biological Medicinal Products Product Portfolio
  84. 8.14.5 Novartis AG Recent Developments
  85. 8.15 Pfizer Inc
  86. 8.15.1 Pfizer Inc Company Information
  87. 8.15.2 Pfizer Inc Business Overview
  88. 8.15.3 Pfizer Inc Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Pfizer Inc Similar Biological Medicinal Products Product Portfolio
  90. 8.15.5 Pfizer Inc Recent Developments
  91. 8.16 Stada Arzneimittel AG
  92. 8.16.1 Stada Arzneimittel AG Company Information
  93. 8.16.2 Stada Arzneimittel AG Business Overview
  94. 8.16.3 Stada Arzneimittel AG Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Stada Arzneimittel AG Similar Biological Medicinal Products Product Portfolio
  96. 8.16.5 Stada Arzneimittel AG Recent Developments
  97. 8.17 Teva Pharmaceutical Industries Ltd
  98. 8.17.1 Teva Pharmaceutical Industries Ltd Company Information
  99. 8.17.2 Teva Pharmaceutical Industries Ltd Business Overview
  100. 8.17.3 Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Product Portfolio
  102. 8.17.5 Teva Pharmaceutical Industries Ltd Recent Developments
  103. 8.18 Viatris
  104. 8.18.1 Viatris Company Information
  105. 8.18.2 Viatris Business Overview
  106. 8.18.3 Viatris Similar Biological Medicinal Products Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Viatris Similar Biological Medicinal Products Product Portfolio
  108. 8.18.5 Viatris Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Similar Biological Medicinal Products Value Chain Analysis
  2. 9.1.1 Similar Biological Medicinal Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Similar Biological Medicinal Products Sales Mode & Process
  6. 9.2 Similar Biological Medicinal Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Similar Biological Medicinal Products Distributors
  9. 9.2.3 Similar Biological Medicinal Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst